High expression of CD109 antigen regulates the phenotype of cancer stem-like cells/cancer-initiating cells in the novel epithelioid sarcoma cell line ESX and is related to poor prognosis of soft tissue sarcoma
about
Epithelioid Sarcoma: Opportunities for Biology-Driven Targeted TherapyGenome-wide association study of toxic metals and trace elements reveals novel associations.Expression of F-actin-capping protein subunit beta, CAPZB, is associated with cell growth and motility in epithelioid sarcoma.A Composite Gene Expression Signature Optimizes Prediction of Colorectal Cancer Metastasis and Outcome.Reduced expression of CD109 in tumor-associated endothelial cells promotes tumor progression by paracrine interleukin-8 in hepatocellular carcinomaCD109 is identified as a potential nasopharyngeal carcinoma biomarker using aptamer selected by cell-SELEXPrognostic impact of CD109 expression in myxofibrosarcoma.CD109, a negative regulator of TGF-β signaling, is a putative risk marker in diffuse large B-cell lymphoma.Immune Therapy for Sarcomas.The future of immunotherapy for sarcoma.Membrane proteome analysis of glioblastoma cell invasion.Peptide vaccination therapy: Towards the next generation.PDE5 inhibition eliminates cancer stem cells via induction of PKA signaling.Myxofibrosarcoma primary cultures: molecular and pharmacological profile.Development of novel monoclonal antibodies against CD109 overexpressed in human pancreatic cancer.CD109 and squamous cell carcinoma.
P2860
Q26782730-0B470F32-B08A-49E0-BB17-5254CAC7E619Q35882587-E1A99D50-55BF-421B-ADC2-E35581B40918Q35953149-CB5E3B92-1B02-4910-B929-6602E8356502Q36714160-5E82C0B0-CD6B-4998-8364-ACE2ED5EAE4AQ37301807-3C85E1E4-5CA9-4633-ADEA-DACED047AF5EQ37688242-E82BE2E2-7B07-4178-8B10-628FCF5EB71FQ38386065-B638EE1D-4B6F-42E2-BBF6-DDA65ED5DD51Q38723891-EE6EA3C5-C592-4FD7-A432-1456944568D2Q38742533-08AB5C70-D1E9-4E1E-814D-566DD843BC0AQ38829558-12FCAB07-CED9-4677-8763-E2DB2CEFBC3EQ38889754-E59B2BF1-B1B0-4D03-8B28-50F626C7B597Q38902336-4EB34EFA-8F9B-465C-BA16-781B4566C81BQ48507592-8B8C1A69-ED69-4E69-B6FF-4861A5D62DEEQ49956275-E4FEBF0F-3AF2-4A90-BCCC-60565BA22A5AQ55004536-9AAAC854-CB6C-40DF-85E2-B0D8FD4B1D45Q55025939-E6D06E92-4910-44C1-9FD0-DCAC4675DC02
P2860
High expression of CD109 antigen regulates the phenotype of cancer stem-like cells/cancer-initiating cells in the novel epithelioid sarcoma cell line ESX and is related to poor prognosis of soft tissue sarcoma
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
High expression of CD109 antig ...... ognosis of soft tissue sarcoma
@ast
High expression of CD109 antig ...... ognosis of soft tissue sarcoma
@en
High expression of CD109 antig ...... ognosis of soft tissue sarcoma
@en-gb
High expression of CD109 antig ...... ognosis of soft tissue sarcoma
@nl
type
label
High expression of CD109 antig ...... ognosis of soft tissue sarcoma
@ast
High expression of CD109 antig ...... ognosis of soft tissue sarcoma
@en
High expression of CD109 antig ...... ognosis of soft tissue sarcoma
@en-gb
High expression of CD109 antig ...... ognosis of soft tissue sarcoma
@nl
prefLabel
High expression of CD109 antig ...... ognosis of soft tissue sarcoma
@ast
High expression of CD109 antig ...... ognosis of soft tissue sarcoma
@en
High expression of CD109 antig ...... ognosis of soft tissue sarcoma
@en-gb
High expression of CD109 antig ...... ognosis of soft tissue sarcoma
@nl
P2093
P2860
P3181
P1433
P1476
High expression of CD109 antig ...... ognosis of soft tissue sarcoma
@en
P2093
Akari Takahashi
Hiroko Asanuma
Hiroshi Iwasaki
Jun Nishio
Kazuyo Yasuda
Kenji Murata
Makoto Emori
Masaki Murase
Masanobu Kano
Mitsunori Kaya
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0084187
P407
P577
2013-01-01T00:00:00Z